Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT02005159
Eligibility Criteria:
Inclusion Criteria:
* \>17 years old
* Clinically significant bacteremia
* Have received treatment fulfilling all this criteria:
1. Treated with an only active antibiotic with enterobacteria (association with vancomycin, linezolid, daptomycin, metronidazole or clindamycin) between: cefotaxime, ceftriaxone, ceftazidime, cefepime, amoxicillin/clavulanic, piperacillin/tazobactam, ertapenem, imipenem, meropenem, ciprofloxacin or levofloxacin
2. First antibiotic dose was administered during the first 12 hours after the time of sampling
3. The antibiotic dosage was at least the advised amount in the summary of product characteristics to patient renal function
4. The same antibiotic has been administered during at least 48 hours.
Exclusion Criteria:
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Study:
NCT02005159
Study Brief:
Protocol Section:
NCT02005159